2018
DOI: 10.1038/s41418-017-0054-7
|View full text |Cite
|
Sign up to set email alerts
|

EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation

Abstract: Mice deficient in epidermal growth factor receptor (Egfr−/− mice) are growth retarded and exhibit severe bone defects that are poorly understood. Here we show that EGFR-deficient mice are osteopenic and display impaired endochondral and intramembranous ossification resulting in irregular mineralization of their bones. This phenotype is recapitulated in mice lacking EGFR exclusively in osteoblasts, but not in mice lacking EGFR in osteoclasts indicating that osteoblasts are responsible for the bone phenotype. Ex… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
59
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(65 citation statements)
references
References 41 publications
(52 reference statements)
1
59
0
Order By: Relevance
“…EGFR signaling pathway is an important bone regulator, whereas it primarily plays an anabolic role in bone metabolism. The suppression of the IGF‐1R/mTOR‐pathway by the EGFR/ERK/IGFBP‐3 signaling is necessary to balance the osteoblast differentiation/maturation providing a mechanism for the skeletal phenotype observed in EGFR‐deficient mice . EGFR signaling is important for maintaining osteoprogenitor population at an undifferentiated stage reducing the expression of two major osteoblastic transcription factors, Runx2 and SP7/Osterix, in osteoblast differentiating cells .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…EGFR signaling pathway is an important bone regulator, whereas it primarily plays an anabolic role in bone metabolism. The suppression of the IGF‐1R/mTOR‐pathway by the EGFR/ERK/IGFBP‐3 signaling is necessary to balance the osteoblast differentiation/maturation providing a mechanism for the skeletal phenotype observed in EGFR‐deficient mice . EGFR signaling is important for maintaining osteoprogenitor population at an undifferentiated stage reducing the expression of two major osteoblastic transcription factors, Runx2 and SP7/Osterix, in osteoblast differentiating cells .…”
Section: Discussionmentioning
confidence: 99%
“…The suppression of the IGF-1R/mTORpathway by the EGFR/ERK/IGFBP-3 signaling is necessary to balance the osteoblast differentiation/maturation providing a mechanism for the skeletal phenotype observed in EGFR-deficient mice. 35 EGFR signaling is important for maintaining osteoprogenitor population at an undifferentiated stage reducing the expression of two major osteoblastic transcription factors, Runx2 and SP7/Osterix, in osteoblast differentiating cells. 36 Runx2 and SP7 are transcription factors necessary for bone formation and responsible for controlling the differentiation of MSCs in osteoblasts.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, in myocardial ischaemia reperfusion injury, AMPK activates OPA‐required mitochondrial fusion and the latter inhibits mitochondrial apoptosis. Furthermore, in liver cancer, the AMPK pathway modulates mitochondrial homeostasis via upregulating PGC1 expression . In addition to Mfn1, several research studies have established the role of Mfn1 in mitochondrial damage.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, in liver cancer, the AMPK pathway modulates mitochondrial homeostasis via upregulating PGC1 expression. 72,73 In addition to Mfn1, several research studies have established the role of Mfn1 in mitochondrial damage. For example, Mfn1 activation is associated with mitochondrial autophagy activation.…”
Section: Discussionmentioning
confidence: 99%
“…The above results suggest that psoralen promotes osteoclast differentiation by activating the ERK signaling, and this pathway accelerates osteoblast differentiation (39). To determine whether psoralen promotes the MAPK signaling pathway during osteoblastogenesis, MC3T3‐E1 cells were or were not treated with psoralen for 0, 5, 10, 20, 30, and 60 min.…”
Section: Resultsmentioning
confidence: 95%